Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro

Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest Posaconazole Prophylaxis in Experimental Systemic Zygomycosis In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes Interactions between Triazoles and Amphotericin B in Treatment of Disseminated Murine Infection by Fusarium oxysporum Combined Therapies in a Murine Model of Blastoschizomycosis Correlation of In Vitro Activity, Serum Levels, and In Vivo Efficacy of Posaconazole against Rhizopus microsporus in a Murine Disseminated Infection Synergistic Activities of Azithromycin and Amphotericin B against Naegleria fowleri In Vitro and in a Mouse Model of Primary Amebic Meningoencephalitis